Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease

被引:0
|
作者
Santangelo, G.
Vitale, C.
Trojano, L.
Verde, F.
Cozzolino, A.
Barone, P.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S250 / S250
页数:1
相关论文
共 50 条
  • [41] Pathological gambling secondary to dopaminergic therapy in Parkinson's disease
    Drapier, Dominique
    Drapier, Sophie
    Sauleau, Paul
    Derkinderen, Pascal
    Damier, Philippe
    Allain, Herve
    Verin, Marc
    Millet, Bruno
    PSYCHIATRY RESEARCH, 2006, 144 (2-3) : 241 - 244
  • [42] Impulse control disorders and pathological gambling in patients with Parkinson disease
    Stamey, William
    Jankovic, Joseph
    NEUROLOGIST, 2008, 14 (02) : 89 - 99
  • [43] Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
    Zand, Ramin
    EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 183 - 186
  • [44] Pathological Gambling in Parkinson's disease patients: Dopaminergic medication or personality traits fault?
    Brusa, L.
    Pavino, V.
    Massimetti, M. C.
    Ceravolo, R.
    Stefani, S.
    Stanzione, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 366 : 167 - 170
  • [45] Respiratory Dysfunctions in Parkinson's Disease Patients
    Docu Axelerad, Any
    Stroe, Alina Zorina
    Arghir, Oana Cristina
    Docu Axelerad, Daniel
    Gogu, Anca Elena
    BRAIN SCIENCES, 2021, 11 (05)
  • [46] Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease
    Pontieri, Francesco E.
    Assogna, Francesca
    Pellicano, Clelia
    Cacciari, Claudia
    Pannunzi, Sara
    Morrone, Annalucia
    Danese, Emanuela
    Caltagirone, Carlo
    Spalletta, Gianfranco
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (01) : 69 - 76
  • [47] The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
    Vazey, Elena M.
    Aston-Jones, Gary
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2012, 6
  • [48] Association between cognitive and autonomic dysfunctions in patients with de novo Parkinson’s disease
    Byung-Euk Joo
    Jihwan You
    Rae On Kim
    Kyum-Yil Kwon
    Scientific Reports, 15 (1)
  • [49] Pathologic gambling in patients with Parkinson's disease
    Gschwandtner, U
    Aston, J
    Renaud, S
    Fuhr, P
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 170 - 172
  • [50] Pathological gambling associated with dopamine agonist therapy in Parkinson's disease
    Driver-Dunckley, E
    Samanta, J
    Stacy, M
    NEUROLOGY, 2003, 61 (03) : 422 - 423